Explore Our Publications
Entrada’s commitment to publications & transparency
Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.
Past Presentations
-
Utility of a 3D–Engineered Skeletal Muscle Organoid System to Assess Exon Skipping, Dystrophin Protein Restoration, and Functional Improvement in a Human DMD Cell Model
- By: Nelsa Estrella, PhD, Associate Director, Neuromuscular, Entrada Therapeutics
- At: Society for Muscle Biology: Skeletal Muscle Stem Cells in Development Regenerations & Adaptations Conference
- On: July 14, 2024
DownloadJuly 14, 2024 -
Durable Exon Skipping and Dystrophin Production with Endosomal Escape Vehicle (EEV™) - Oligonucleotide Conjugates in Preclinical Models of DMD
- By: Xiang Li, PhD, Director, Discovery Research, Entrada Therapeutics
- At: 2024 RNA Therapeutics: From Concept to Clinic
- On: June 26, 2024
DownloadJune 26, 2024 -
Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle
- By: Mark Shen, PhD, Sr. Scientist, Discovery Research, Entrada Therapeutics
- At: 2024 RNA Therapeutics: From Concept to Clinic
- On: June 26, 2024
DownloadJune 26, 2024 -
Utility of a 3D Engineered Skeletal Muscle Organoid System to Assess Exon Skipping and Dystrophin Protein Restoration in a Human DMD Cell Model
- By: Sara Blake, Research Associate, Neuromuscular, Entrada Therapeutics
- At: 2024 New Directions in Biology and Disease of Skeletal Muscle Conference
- On: June 23, 2024
DownloadJune 23, 2024 -
In Vitro Efficacy of an Endosomal Escape Vehicle (EEV™) – DMD Exon 45 Skipping Oligonucleotide Conjugate in DMD Patient-Derived Skeletal and Cardiac Muscle Cells
- By: Christopher Brennan, PhD, Sr. Scientist, Neuromuscular, Entrada Therapeutics
- At: 2024 New Directions in Biology and Disease of Skeletal Muscle Conference
- On: June 23, 2024
DownloadJune 23, 2024 -
Durable Exon Skipping and Dystrophin Production with Endosomal Escape Vehicle (EEV™) - Oligonucleotide Conjugates in Preclinical Models of DMD
- By: Jia Qi Cheng Zhang, PhD, Scientist, Neuromuscular, Entrada Therapeutics
- At: 2024 New Directions in Biology and Disease of Skeletal Muscle Conference
- On: June 23, 2024
DownloadJune 23, 2024